pemphigus
pemphigus
Explore linked clinical trials. Standard reference: MONDO:000659416 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Not yet recruiting | Early phase 1 | 2026-08-18 | NCT07769333 | |
| ONO-4059 Study in Patients With Steroid-resistant Pemphigus | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Active, not recruiting | Phase 3 | 2026-07-20 | NCT06696716 | |
| CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Recruiting | Not applicable | 2026-07-02 | NCT07681388 | |
| A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Recruiting | Phase 1 / Phase 2 | 2026-05-29 | NCT04422912 | |
| A Clinical Study of B007 in the Treatment of Pemphigus. | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Recruiting | Phase 2 / Phase 3 | 2026-05-05 | NCT06454357 | |
| Autoimmune Blistering Diseases Study | Skin and Connective Tissue Diseases, autoimmune disease, bullous pemphigoid, immune system disorder, pemphigus, pemphigus foliaceus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Recruiting | Not stated | 2026-03-30 | NCT02753777 | |
| Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Recruiting | Phase 4 | 2026-02-20 | NCT05898308 | |
| FARD (RaDiCo Cohort) (RaDiCo-FARD) | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Conjunctival Diseases, Eye Diseases, Hereditary, Infant, Newborn, Diseases, Keratoderma, Palmoplantar, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Nutritional and Metabolic Diseases, Pemphigoid, Benign Mucous Membrane, Skin Abnormalities, Skin and Connective Tissue Diseases, albinism, autoimmune disease, ectodermal dysplasia syndrome, eye disorder, hereditary disease, hereditary neoplastic syndrome, hereditary skin disorder, hypopigmentation of the skin, ichthyosis, immune system disorder, inborn disorder of amino acid metabolism, inborn errors of metabolism, incontinentia pigmenti, inherited epidermolysis bullosa, inherited neurodegenerative disorder, keratosis, metabolic disease, mucous membrane pemphigoid, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, pemphigus, peripheral nervous system disorder, skin disorder, skin pigmentation disorder, vesiculobullous skin disease | Recruiting | Not stated | 2026-02-12 | NCT05954416 | |
| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Active, not recruiting | Phase 2 | 2025-07-08 | NCT04400994 | |
| Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients. | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Not yet recruiting | Not applicable | 2025-05-14 | NCT06971172 | |
| A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Active, not recruiting | Not stated | 2025-04-29 | NCT06949241 | |
| A Single-center Study of CM313 in Patients With Pemphigus | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Not yet recruiting | Not applicable | 2025-04-01 | NCT06904040 | |
| Impact of a Lifestyle Program on Quality of Life in Pemphigus Patients | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Not yet recruiting | Not applicable | 2025-03-30 | NCT06901427 | |
| Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation. | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Not yet recruiting | Not stated | 2025-03-07 | NCT06863454 | |
| A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313. | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Not yet recruiting | Phase 1 / Phase 2 | 2024-10-29 | NCT06663943 | |
| Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, musculoskeletal system disorder, necrotizing vasculitis, pemphigus, pemphigus vulgaris, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, systemic lupus erythematosus, vascular disorder, vasculitis, vesiculobullous skin disease | Recruiting | Phase 1 | 2024-09-03 | NCT06581562 |